“Real transformation shows up in integrated systems that reduce manual effort. It shows up in teams that can release capability without navigating multiple approval layers. It shows up in measurable improvements to cycle time, implementation speed, and user confidence.”
- Applied Clinical Trials-06-01-2026
- Volume 35
- Issue 3
When Governance Outpaces Product: Why Pharma Modernization Stalls Before It Ships
Pharma modernization initiatives stall not from lack of ambition but from expanding governance layers that distance leadership from execution, slowing decision velocity and delaying the systems integration that drives competitive advantage.
Pharma is modernizing.
Digital platforms are replacing manual workflows. Data systems are expanding across trials. Artificial intelligence initiatives are moving from pilot programs to enterprise planning. Patient engagement tools are becoming operational expectations.
On paper, transformation is underway.
Inside many organizations, governance layers are expanding faster than execution capacity. Leadership roles are multiplying in the name of alignment. Product teams are moving more slowly, not faster.
Modernization rarely fails because of a lack of ambition. It stalls because of structural distance.
Transformation is not a hiring strategy
When digital transformation becomes strategic, the instinct is often to add leadership. A vice president to drive innovation. A chief digital officer to coordinate across functions. A head of transformation to manage complexity.
In regulated environments, governance matters. Risk management matters. Cross-functional alignment matters. But complexity does not automatically require more hierarchy.
As layers increase, the distance between strategy and execution widens. Decisions travel through more reviews. Trade-offs require more approvals. Alignment meetings multiply. Product teams wait for clarity. The org chart looks mature. Delivery velocity slows.
Modernization does not stall because teams lack capability. It stalls because ownership becomes diffuse and decision authority becomes abstract.
Digital transformation requires proximity
Pharma modernization initiatives sit at the intersection of product, compliance, science, and operations. That intersection demands leaders who understand nuance. It does not benefit from leaders who are insulated from the work.
The teams configuring systems, integrating platforms, and deploying digital tools experience friction first. They know where processes break. They understand vendor constraints. They see which tradeoffs are theoretical and which are operational.
When leadership stays close to that signal, execution improves.
When leadership expands upward while proximity decreases, signal weakens. Strategy becomes narrative rather than instruction. Execution becomes reactive rather than directed.
In capital-intensive environments, distance is expensive. It shows up in extended implementation timelines, delayed integrations, and initiatives that take longer than forecasted.
Modernization is not proven by announcing strategy. It is proven by shipped capability.
Governance without clarity creates theater
Governance is not the problem. Governance without clarity is. As digital initiatives scale, steering committees form. Working groups multiply. Road maps become more detailed. Presentations improve. But clarity of ownership often declines.
- Who has final authority over product direction?
- Who can make trade-offs between scope and speed?
- Who decides when something is ready to move forward?
Without clear answers, governance becomes performance. The appearance of coordination replaces the reality of progress. Modernization is not proven by strategy decks. It is proven by shipped capability.
External leadership can help, but only if embedded
Bringing in experienced leaders can accelerate transformation. Cross-industry perspective matters. Pattern recognition matters. But modernization cannot be driven from a distance.
Effective leaders spend time with implementation teams. They understand system constraints. They engage directly with internal users. They observe friction rather than hearing about it secondhand. Strategy without immersion becomes theory.
Transformation requires participation. When leaders embed themselves in the operational layer, governance sharpens rather than expands. Decisions accelerate because context improves. Trust builds because proximity is visible.
A structural question for executive teams
If modernization is strategic, leadership design should support execution velocity. Before adding another title or governance layer, organizations might ask the following.
Questions worth asking
Focus area questions
- Ownership: Who has clear authority to make product decisions today?
- Velocity: Has decision speed improved as leadership expanded?
- Proximity: How often do senior leaders engage directly with execution teams?
- Signal: Where does operational friction surface first, and is it acted upon?
- Structure: Would delivery accelerate if one approval layer were removed?
These are structural questions, not cultural ones. In pharma, delayed modernization compounds cost. Systems remain fragmented. Teams compensate manually. Data stays siloed. Competitive advantage narrows.
Governance that outpaces product does not reduce risk. It shifts risk into slower execution and reduced adaptability.
Execution is the real signal
Modernization is not about how many people oversee the work. It is about how effectively the work moves.
In regulated industries, complexity is inevitable. Distance is not. The organizations that modernize successfully are not the ones with the most elaborate governance structures. They are the ones where product ownership is clear, decision rights are explicit, and leaders remain close enough to execution to see friction before it compounds.
Real transformation shows up in integrated systems that reduce manual effort. It shows up in teams that can release capability without navigating multiple approval layers. It shows up in measurable improvements to cycle time, implementation speed, and user confidence.
Governance has a role. So does leadership. But when structure expands faster than clarity, modernization slows under its own weight.
If digital initiatives take longer each year despite more leadership oversight, the structure deserves scrutiny.
In capital-intensive environments, velocity is not optional. The organizations that win will be those that treat execution as the primary signal, not the byproduct of governance.
About the author
Brian Ongioni is the founder of
Articles in this issue
4 days ago
Getting Ahead in Trial Design




